Benjamin R Yerxa insider trades

Open-market stock purchases and sales by Benjamin R Yerxa, President at Opus Genetics, Inc, from SEC Form 4 filings since Jan 4, 2010.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +110%.

Recent trades

DateStockTradeValue
Jul 23, 2026IRD Opus Genetics, IncSold$22.1K
Apr 23, 2026IRD Opus Genetics, IncSold$39.1K
Jan 22, 2026IRD Opus Genetics, IncBought (not open market)—

Companies traded

  • IRD Opus Genetics, Inc: 1 buy, 2 sales, last Jul 23, 2026
  • CLSD Clearside Biomedical, Inc: 1 buy, last Jun 20, 2024
  • ISPH Inspire Pharmaceuticals Inc: 28 sales, last May 12, 2010

Get free alerts when Benjamin R Yerxa files a new trade →